Sample | Title | Value | Rank |
GSM132917 | SKI-DLCL cells_untreated_24h_1rpt | 95.4 | 69 |
GSM132918 | SKI-DLCL cells_untreated_24h_2rpt | 92.2 | 69 |
GSM132920 | SKI-DLCL cells_untreated_24h_rpt3 | 75.9 | 66 |
GSM132941 | SKI-DLCL cells_Aplidin 3nM_24h_rpt1 | 100.8 | 71 |
GSM132944 | SKI-DLCL cells_Aplidin 3.0nM_24h_rpt2 | 99.9 | 70 |
GSM132947 | SKI-DLCL cells_Aplidin treated 3nM_24h_rpt3 | 79.5 | 67 |
GSM132949 | SKI-DLCL cells_AraC 20nM_24h_rpt1 | 77.6 | 66 |
GSM132950 | SKI-DLCL cells_AraC 20nM_24h_rpt2 | 84.4 | 67 |
GSM132953 | SKI-DLCL cells_AraC 20nM_24h_rpt3 | 85.9 | 67 |
GSM132955 | SKI-DLCL cells_Aplidin 1.5nM AraC 5nM_24h_rpt1 | 104.1 | 71 |
GSM132956 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5nM_24h_rpt2 | 104.3 | 71 |
GSM132960 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5.0 nM_24h_rpt3 | 63.2 | 64 |
GSM132760 | SKI-DLCL_tumor_untreated animals | 93.5 | 66 |
GSM132916 | SKI-DLCL_tumor_animals treated with 1mg/kg Aplidin_50mg/kg AraC | 54.5 | 57 |